Please provide your email address to receive an email when new articles are posted on . Presbyopia is the second most common refractive error in the United States ...

Vuity contracts the iris sphincter muscle, constricting the pupil to improve near and intermediate visual acuity. The Food and Drug Administration (FDA) has approved the supplemental New Drug ...

Tenpoint Therapeutics, Ltd., a global, commercial-ready biotechnology company focused on developing groundbreaking treatments to rejuvenate vision in the aging eye, today announced that its partner, ...

SAN DIEGO, Oct. 21, 2024 (GLOBE NEWSWIRE) -- LENZ Therapeutics, Inc. (LENZ) (Nasdaq: LENZ or “LENZ” or the “Company”), a pre-commercial biopharmaceutical company focused on the development and ...

Zhaoke Ophthalmology Ltd. ( ($HK:6622) ) has issued an update. Zhaoke Ophthalmology Ltd. has entered into a distribution agreement with PT Ferron ...

VIZZTM (aceclidine ophthalmic solution) 1.44% received FDA approval for the treatment of presbyopia Commercial product launch initiated in October 2025 with broad product availability in mid-Q4 2025 ...

A combination eye drop helped patients with presbyopia improve visual acuity, according to a study presented at the European ...

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Presbyopia pipeline constitutes 6+ key companies continuously working towards developing 6+ Presbyopia treatment ...

The MarketWatch News Department was not involved in the creation of this content. The launch of emerging therapies, such as LNZ100 by Lenz Therapeutics, Phentolamine Ophthalmic Solution 0.75% by ...

LNZ100 shows superior efficacy and safety in presbyopia treatment, with a strong probability of FDA approval by August 2025. LNZ100 outperforms competitors Vuity and Qlosi, offering faster and greater ...

VIZZ is the first and only aceclidine-based eye drop approved to improve near vision in adults with presbyopia, a condition impacting approximately 128 million adults in the United States First once ...

The Myopia and Presbyopia Treatment Market is experiencing significant growth due to the increasing prevalence of vision loss from nearsightedness and age-related presbyopia. Elderly people and ageing ...